This is a New Era.

We believe that bringing genomic precision to the practice of dermatology is ushering in a new era of patient care. One that is not just better, but different.

Where doctors can see more objective data to help them make more accurate diagnoses, eliminate unnecessary surgeries, and lower costs. Where patients have more options, and more information. Where we all work together to change skin cancer as we know it. We believe everyone who needs it should have access to high quality care. Here is some information to help you get started.

Have a question?
» Contact Us

Discovery

Medicare covers the DermTech Melanoma Test

When ordered by your doctor, the test can be done remotely under your doctor’s supervision. 

For more information, contact us at 1-866-450-4223, ext 155.

Discovery

The DermTech Insurance Process

 

A DermTech test is easy to work into your current insurance plan. See the steps you can expect below. And if you have any questions, our patient concierge team is always ready to help you and your carrier work through any issues.

Call us at 866-450-4223 ext. 156.

Have a question?
» Contact Us

one

The Claim

We’ll take care of the claim — after your test has been reported to your physician, DermTech will submit our laboratory claim for the Melanoma Test to your insurance company on your behalf. This claim is in addition to your doctor’s claim.

one

The Explanation of Benefits

After processing your claim, your insurance company will likely send you an Explanation of Benefits (EOB). The EOB is not a bill. You should review and contact our billing department with any questions.

one

The Appeal

If your insurance company does not cover all or a portion of the cost of the test, we will work with you and appeal the decision on your behalf.

one

The Patient Portion

If any additional cost remains once your insurance company finalizes your claim, DermTech will send you a bill with any patient responsibility.

Discovery

It’s Quick and Easy
to DermTech It

It’s Quick and Easy
to DermTech It

LIFT

You and your doctor use a series of smart stickers to painlessly collect skin cells from a suspicious mole — no scalpel needed. This can be done at a doctor’s office, or remotely via telehealth with your doctor’s supervision.

TEST

At DermTech’s Gene Lab, a proprietary process looks for the presence of elevated expression levels of two genes proven to correlate with melanoma, named LINC00518 and PRAME.

KNOW

Results are sent to your physician in about 3 business days. Your doctor will use this information to choose the best path forward for your treatment. If the genomic markers are there, this will typically result in removal of the mole. If not, you’ve likely saved yourself a scar.

» Download Brochure

Discovery

DermTech It via Telehealth

Staying at home doesn’t mean waiting for answers. Your dermatologist can order the DermTech Melanoma Test through a telehealth visit, then guide you through the easy process of collecting your own sample under your doctor’s supervision (download instructions).

See how easy it is.

"

Remote Collection Instruction Video

Discovery

Download Instructions
to DermTech It

The test can be done remotely, with your doctor’s order and supervision. Download these easy instructions to learn how to prep, collect, and send off your DermTech sample remotely.

» Download Instructions

FAQ
What is the DermTech Melanoma Test (PLA)?

The DermTech Melanoma Test is a new kind of lab test that looks for signs of melanoma in your skin’s genomic material. With the traditional biopsy care pathway, clinicians use their eyes — aided by a microscope — to see physical changes to a mole, and the cells within it. The DermTech test uses a gene expression test to analyze the RNA inside those cells.

Because it can find indications of melanoma at this more precise level, the disease can be detected far earlier than the current biopsy pathway.17

The DermTech Melanoma Test uses a smart sticker to pull skin tissue off the entire surface of the mole painlessly and without an incision.

How does it work?

If your doctor has identified a suspicious skin spot — maybe one they would normally take a photograph of and track — they can use the DermTech Melanoma test to rule out melanoma (with 99% accuracy, better than the 83% accuracy of the current biopsy care pathway).18,19

Once they have identified the spot, they’ll open the “Adhesive Skin Collection Kit” to begin the test. They’ll use the smart sticker to lift skin tissue off the spot by pressing, rubbing, and lifting the sticker. They’ll do this four times, placing each sticker on the collection strip.

This strip then gets sent to our Gene Lab. At the lab, a DermTech patented process tests your sample for expression levels of two specific genes associated with melanoma, named PRAME and LINC00518.

Results are sent to your physician in about 3 business days. Your doctor will use this information to choose the best path forward for your treatment. If the genomic markers are there, this will typically result in removal of the spot. If not, you’ve likely saved yourself a scar.

» See Demo Video

Does the DermTech Melanoma Test hurt?

Not typically. The sticker uses a proprietary adhesive to lift 1.5 mg of tissue off the top layer of your skin, but it’s not so strong that it would cause pain, bleeding or damage to the site. In certain cases, mild irritation or other effects may occur.

» See Risk Information 

Does the DermTech test replace a biopsy?

The DermTech Melanoma Test is not a replacement for a biopsy. If the genomic markers are there, your doctor will use this information to choose the best path forward for your treatment. This will likely result in removal of the mole. The DermTech Melanoma Test is rather a step before a biopsy that can see indicators of the disease far earlier than the traditional biopsy pathway can.20

Have Another Question?

 

» Contact Us

We’re here to help, whether that’s guiding you through the process, answering your questions, or helping you find a DermTech specialist. Give us a call, send us an e-mail, or chat with us.